DCS offers a comprehensive suite of services in drug discovery and development, designed to accelerate the path from research to market. Through Computational Drug Design & Modeling, DCS leverages AI and machine learning for molecular modeling and virtual screening, optimizing potential drug candidates. Their Good Laboratory Practices (GLP) Compliance Services ensure that labs meet regulatory standards, providing auditing, training, and certification. Pharmacovigilance & Safety Monitoring services focus on tracking drug safety, reporting adverse events, and implementing risk management strategies. DCS also provides expert Regulatory Affairs & Compliance Consulting, assisting companies in preparing and submitting documentation for global regulatory approval. Finally, Health Economics and Outcomes Research (HEOR) and Clinical Trials & Pharmacokinetics Support services ensure that drug therapies are both effective and economically viable, maximizing their impact.